首页> 外文期刊>Breast cancer >The Evolving Non-Surgical Ablation of Breast Cancer: MR Guided Focused Ultrasound (MRgFUS)
【24h】

The Evolving Non-Surgical Ablation of Breast Cancer: MR Guided Focused Ultrasound (MRgFUS)

机译:不断发展的非手术性消融术:MR引导聚焦超声(MRgFUS)

获取原文
           

摘要

MRgFUS (MR guided Focused Ultrasound) being one of the non-surgical ablation techniques. We have already achieved favorable results in the past clinical study of MRgFUS to local treatment. New twenty one cases of invasiveoninvasive ductal carcinoma of the breast were treated by MRgFUS. Core needle biopsy led to the definitive diagnosis. All the patients were positioned prone in the treatment, using the therapeutic apparatus such as Signa Excite 1.5T for MRI and ExAblate 2000 version 2.6/4.1 for FUS. Irradiation was not applied to all the 21 cases after MRgFUS. Axillary lymph node metastases were examined by dissection or sentinel lymph node biopsy. Recurrence or abnormal area of residual cancer was treated with Re-MRgFUS or ablated by usual surgery. All the 21 cases were from women patients. Median age is 54 years (range: 34-72). Median diameter of tumor is 15 mm (range: 5-50). As for the numbers of treatment, 17 patients were treated once, and 4 patients twice. Median period of observation is 14 months (range: 3-26). One case of recurrence of pure mucinous carcinoma was experienced. No evidences of recurrence were obtained through MRI for the rest of 20 cases. Skin burns were found in 2 cases. The patient had dimple on the skin immediately above tumor. In conclusion, MRgFUS is a good mean as local control of breast cancer, but the indicated case must be selected strictly. And it needs to observe longer the patients who ware treated by MRgFUS alone.
机译:MRgFUS(MR引导聚焦超声)是一种非手术消融技术。在过去的MRgFUS局部治疗的临床研究中,我们已经取得了令人满意的结果。 MRgFUS治疗了21例乳腺浸润性/非浸润性导管癌。穿刺活检导致了明确的诊断。使用治疗设备(例如用于MRI的Signa Excite 1.5T和用于FUS的ExAblate 2000版本2.6 / 4.1)将所有患者俯卧在治疗中。 MRgFUS术后21例均未接受放射治疗。通过解剖或前哨淋巴结活检检查腋窝淋巴结转移。残余癌的复发或异常区域用Re-MRgFUS治疗或通过常规手术切除。 21例均来自女性患者。中位年龄为54岁(范围:34-72岁)。肿瘤的中值直径为15毫米(范围:5-50)。至于治疗次数,一次治疗17例,两次治疗4例。观察的中位数为14个月(范围:3-26)。发生了纯粘液癌复发1例。其余20例均未通过MRI获得复发证据。 2例发现皮肤烧伤。该患者在肿瘤上方的皮肤上有酒窝。总之,MRgFUS是局部控制乳腺癌的良好手段,但必须严格选择适应症。而且需要观察更长的时间,那些仅接受MRgFUS治疗的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号